ESC Professional Premium Access

Lipoprotein(a) and the risk of major adverse limb events in patients with stable atherosclerotic vascular disease

Congress Presentation

About the speaker

Doctor Marc Bonaca

University of Colorado Anschutz Medical Campus, Aurora (United States of America)
30 presentations
1 follower

8 more presentations in this session

Reduction in the risk of major adverse limb events with ezetimibe versus placebo in addition to statin therapy: insights from the IMPROVE IT trial

Speaker: Doctor M. Bonaca (Aurora, US)

Thumbnail

The impact of Covid-19 on mortality and clinical characteristics in hospitalized patients with peripheral artery disease in the year 2020

Speaker: Professor C. Hehrlein (Freiburg, DE)

Thumbnail

Association between electronic nicotine delivery systems use and risk of stroke: A systematic review and meta-analysis of observational studies with 822,162 participants.

Speaker: Professor M. Banach (Lodz, PL)

Thumbnail

Olive extract enriched with hydroxytyrosol improves cardiac and vascular function in patients with stable coronary artery disease: a double-blind, placebo-controlled trial.

Speaker: Doctor I. Ikonomidis (Athens, GR)

Thumbnail

Of mice and men: transcriptome-based clustering reveals molecular heterogeneity among mouse atherosclerosis models and partially reflects the diversity of human plaques

Speaker: Mr E. Brouwer (Utrecht, NL)

Thumbnail

Access the full session

Arterial occlusive disease: a chronic pandemic needing attention to detail

Speakers: Doctor M. Bonaca, Doctor M. Bonaca, Professor C. Hehrlein, Professor M. Banach, Doctor I. Ikonomidis...
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations